Effects of diltiazem on thromboxane B2 production from platelet-rich plasma and whole blood

This publication has 25 references indexed in Scilit:

• Studies on inhibition of human platelet response by diltiazem
  General Pharmacology: The Vascular System, 1990
• Effects of oral diltiazem on platelet function: alone and in combination with “low dose” aspirin
  Thrombosis Research, 1986
• Platelet Activation in Unstable Coronary Disease
  New England Journal of Medicine, 1986
• Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon.
  BMJ, 1986
• Calcium Blocker Diltiazem Inhibits Platelet Activation and Stimulates Vascular Prostacyclin Synthesis
  The Lancet Healthy Longevity, 1986
• Urinary excretion of 2,3-dinor-thromboxane B2 in man under normal conditions, following drugs and during some pathological conditions
  Prostaglandins, 1984
• Effect of diltiazem in patients with variant angina: A randomized double-blind trial
  American Heart Journal, 1981
• Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart Disease
  New England Journal of Medicine, 1981
• Polymorphonuclear leukocytes produce thromboxane A2-like activity during phagocytosis
  Prostaglandins, 1976
• On the Formation and Effects of Thromboxane A₂ in Human Platelets
  Acta Physiologica Scandinavica, 1976